New cancer clinical trial: Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Published on: December 25, 2018 at 12:00PM
Condition:   Prostate Cancer
Interventions:   Drug: Olaparib;   Drug: AZD6738
Sponsor:   University of Michigan Cancer Center
Not yet recruiting
http://bit.ly/2GFnVTS